Uncategorized

Adi Mohanty Is Progenity’s New CEO

Progenity, a biotech company innovating in the fields of women’s health, gastrointestinal health, and oral biotherapeutics had announced Adi Mohatny as the company’s new CEO. he also joins Progenity’s Board of Directors. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide…

Aidoc and ScreenPoint Medical Announce a New Partnership to Provide a Complete AI Solution for Breast Imaging

Aidoc, a leading provider of AI for medical imaging, and ScreenPoint Medical, a leader of deep learning AI for 2D and 3D mammography have announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging specialists will now be able to benefit from one point of access to AI within the existing physician workflow, providing for early detection and diagnosis of…

Maternal-Fetal-Health Company Raydiant Oximetry Raises $5M to Support a Clinical Study at UTMB

Medical device company Raydiant Oximetry. has announced an oversubscribed round of $5M Series A2 financing. The funding was led by Avestria Ventures, which invests in early-stage women’s health companies, and syndicated by KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures, SteelSky Ventures and Tri-Valley Ventures. Raydiant Oximetry is a clinical-stage medical device company focused on improving women’s and neonatal health. Its…

Only 26% of Pregnant People in the U.S. Are Vaccinated Against COVID-19. Here’s Why.

Maven, the virtual clinic for women’s and family health, has released findings from a recent study that sheds light on why so many pregnant people are hesitant to get the COVID-19 vaccine despite recommendations from the Centers for Disease Control and Prevention (CDC). The findings come as the rate of vaccination among pregnant people remains low, with just 26% of pregnant people…

The Lundquist Institute Receives $3M From the NIH To Expand its Male Contraception Study

The Lundquist Institute announced that its Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health (NIH) to expand its work and recruit 120+ more couples. This NIH funding will bring the total number of couples involved in the study to over 400. Besides adding couples at Lundquist in Los Angeles, more couples will be recruited in Sacramento, California (UC Davis), Norfolk,…

Organon Teams Up with Flat6Labs to Launch a New Femtech Accelerator Program in the Middle East & North Africa

Women’s health pharma company Organon and Flat6Labs are launching a new femtech accelerator program to help female-founded digital health start-ups, across the Middle East and North Africa (MENA), succeed by providing support to build products, test market fit, and improve their business models. The announcement was made at a thought leadership panel discussion hosted by Organon at EXPO 2020 in Dubai. Held…

Femtech Trendwatch: Investment Round-up October, Male Contraceptives on the Rise & The Hims Story

Every Monday we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief get an overview of last month’s femtech investments , plus… Contraline and the Rise of ‘Male Contraceptives’ The Hims Story Femtech Investments: October 2021 As every month we share…

Pregnancy Nutrition Startup Needed Raises $5.8M to Expand its Offering and Invest in Clinical Research

Los Angeles-based perinatal nutrition and education startup Needed has announced a $5.8M seed round led by Seae Ventures and Sekhmet Ventures. Other participants in the the round include Crescent Ridge Partners and Peterson Partners. The company plans to use the new round of funding to expand its offering and address sleep, stress, and fertility issues. Needed is a pregnancy nutrition and education…